Similar articles

• Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.

  Dalbeth N, Doyle AJ, McQueen FM, Sundy J, Baraf HS. Dalbeth N, et al. Arthritis Care Res (Hoboken). 2014 Jan;66(1):82-5. doi: 10.1002/acr.22059. Arthritis Care Res (Hoboken). 2014. PMID: 23836458
• Reversal of chronic refractory tophaceous gout with erosions with pegloticase.

  Yeter KC, Ortiz EC, Arkfeld DG. Yeter KC, et al. Int J Rheum Dis. 2013 Jun;16(3):369-70. doi: 10.1111/1756-185X.12073. Epub 2013 May 23. Int J Rheum Dis. 2013. PMID: 23981765 No abstract available.
• Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient disease.

  Bacani AK, McCollough CH, Glazebrook KN, Bond JR, Michet CJ, Milks J, Manek NJ. Bacani AK, et al. Rheumatol Int. 2012 Jan;32(1):235-9. doi: 10.1007/s00296-009-1295-7. Epub 2009 Dec 17. Rheumatol Int. 2012. PMID: 20016988
• Treatment failure gout.

  Ali S, Lally EV. Ali S, et al. Med Health R I. 2009 Nov;92(11):369-71. Med Health R I. 2009. PMID: 19999896 Review. No abstract available.
• Pegloticase for treating refractory chronic gout.

  George RL Jr, Sundy JS. George RL Jr, et al. Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Drugs Today (Barc). 2012. PMID: 22844655 Review.